RE: Remove the Cancer7 Nov 2025 11:55
Optimisation like has happened at CB? Like a pump for Cas 3? Like the compressor? In my opinion the major issues have been with Cas4, fundraises and contracts. The CEO will be relying on his operations team, FD and legal team for advice and execution on those. Yes, the buck ultimately rests with PB, but without knowing the details, changing the CEO might not resolve the above issues. PB deserves some credit for building the business, the team, not overpaying for TRIN and acquiring CB.